High quality Canagliflozin 99% high purity white powder CAS 842133-18-0 for weight loss and lowering blood sugar

Description

Product Detail
Descriptions. Canagliflozin is used together with proper diet and exercise to treat type 2 diabetes. It is also used to lower the risk of heart attack, stroke, or death in patients with type 2 diabetes and heart or blood vessel disease. This medicine works in the kidneys to prevent absorption of glucose (blood sugar).

Items Specifications
CAS 842133-18-0
MF C24H25FO5S
MW 444.52
Melting Point 68 - 72°C
EINECS 695-192-1
Storage Store in cool dry environment, away from direct sunlight

FQA
Q1:Can i get free sample ?
A: Yes, most product we can send you small free sample, you just need to pay the shipping cost .

Q2:Which payment method you accept?
A: We accept bank transfer,money gram,bitcoin, USDT,Credit card etc. and more bigger order we accept L/C at sight

Q3: Can i get tracking number after shipment ? and how long does the shipping take?
A: After shipment we will offer you tracking and tell you the website to track the package, usually the shipping time is 3-7days,but for some customers have no ability to declare customs, we use special line route to ship the package, it will take 10-12days to arrive,make sure 100% delivery

Q4: How can you guarantee the quality ?
A: All products we can supply you test report &you can also send our product to the third party to do test, if it is fake,we will full refund you.

Canagliflozin(Invokana) is an oral diabetes medicine that helps control blood sugar levels. It works by helping the kidneys get rid of glucose from your bloodstream. Invokana is used together with diet and exercise to treat type 2 diabetes. To mention the advantage, this drug helps patients to reduce blood sugars without increasing the likelihood of gaining weight as long as a healthy, balanced diet is followed and regular exercise taken.
Canagliflozin is a sodium/glucose cotransporter 2 (SGLT2) inhibitor. Canagliflozin has been shown to dose dependently reduce calculated renal threshold for glucose excretion and increase urinary glucose excretion. Canagliflozin is a candidate for the treatment of type 2 diabetes and obesity.

Canagliflozin is an SGLT2 inhibitor drug, an oral hypoglycemic drug targeting type 2 sodium-glucose cotransporter (SGLT2). SGLT-2 inhibitors have good prospects for the treatment of type 2 diabetes. The effectiveness and safety of the drug have been confirmed through existing clinical trials. Its single use or combined use with metformin and sulfonylureas can significantly reduce HbA1c and fasting blood glucose in patients with type 2 diabetes. The incidence of adverse reactions is similar to that of placebo, and the risk of hypoglycemia is lower, which can significantly reduce body weight.